Non‐resectable congenital tumors with the <i>ETV6</i>–<i>NTRK3</i> gene fusion are highly responsive to chemotherapy

Abstract excerpt

BACKGROUND: Recently, the ETV6-NTRK3 gene fusion has been identified in both infantile fibrosarcoma and cellular mesoblastic nephroma. For both these tumors standard curative treatment has been primarily surgical with wide local excision. This has frequently involved radical and even mutilating surgery. PROCEDURE: This report discusses three infants with congenital tumors, two congenital fibrosarcomas, and one...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroblastoma Research and Treatments
• Share to Renal and related cancers
• Share to Renal cell carcinoma treatment